投资者的过度自信,一度是2018年医药产业投资的主基调。只是,接踵而来的中美贸易摩擦、中国宏观经济状况,以及最新的4+7国家带量采购政策,都在从不同的层面印证此前的预判实在是过度乐观。
本文编辑整理自GBI《2018年中国医疗健康行业IPO、...查看全文
咸达数据2016-04-27 15:55
1 药政背景 2010年海峡两岸关系协会与台湾海峡交流基金会双方签署了《海峡两岸医药卫生合作协议》,旨在促进两岸医药合作,该协议于2011年6月26日正式生效。基于该协议,两岸展开了一系列合作,2014年台湾“食品药物管理署”委托台北荣民总医院启动了《建立两岸临床试验中心合作计划》。在此框架...查看全文
$台湾微脂体(TLC)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001564590-21-056383 Act: 34 Size: 3 MB 网页链接
$台湾微脂体(TLC)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001564590-21-051267 Act: 34 Size: 232 KB 网页链接
$台湾微脂体(TLC)$ CB/A [Amend] Tender Offer/Rights Offering Notification Form Accession Number: 0001193125-21-299062 Act: 34 Size: 1 MB 网页链接
$台湾微脂体(TLC)$ CB/A [Amend] Tender Offer/Rights Offering Notification Form Accession Number: 0001193125-21-295441 Act: 34 Size: 37 KB 网页链接
$台湾微脂体(TLC)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001564590-21-050486 Act: 34 Size: 27 KB 网页链接
$台湾微脂体(TLC)$ 25 Notification of the removal from listing and registration of matured, redeemed or retired securities Accession Number: 0001193125-21-277274 Act: 34 Size: 15 KB 网页链接
$台湾微脂体(TLC)$ CB/A [Amend] Tender Offer/Rights Offering Notification Form Accession Number: 0001193125-21-273945 Act: 34 Size: 534 KB 网页链接
$台湾微脂体(TLC)$ F-X Appointment of Agent for Service of Process and Undertaking Accession Number: 0001193125-21-273683 Act: 33 Size: 22 KB 网页链接
$台湾微脂体(TLC)$ CB/A [Amend] Tender Offer/Rights Offering Notification Form Accession Number: 0001193125-21-267828 Act: 34 Size: 35 KB 网页链接
$台湾微脂体(TLC)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001564590-21-047349 Act: 34 Size: 210 KB 网页链接